ClinicalTrials.gg
Not yet recruitingNCT07902531Updated Oct 29, 2026

Curriculum Design and Effectiveness in Death and Spiritual Care

An interventional study of Death and Spiritual Care Education and Control in Death, Spiritual Care and Spiritual Care Education, sponsored by Cukurova University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Cukurova University · Not applicable, Interventional, and Supportive care

Updated Oct 29, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will be conducted using a randomized experimental design with a pre-test/post-test control group to determine the effectiveness of a curriculum on "Death and Spiritual Care in the Elderly"-developed for students in the Elderly Care Program and based on Jean Watson's Human Caring Model-on the students' death anxiety and spiritual care competencies.

Read the detailed description

The approaches of elderly care students-who will become active members of the care team-toward the dimensions of death and spiritual care are of great importance. Developing positive attitudes toward these concepts will directly enhance the quality of healthcare services provided to elderly individuals.

02

Conditions studied

  • Death
  • Spiritual Care
  • Spiritual Care Education

Browse trials for

Keywords

  • Death
  • Spiritual Care
  • education
03

In context

Death

456 studies on the registry are indexed under Death; 86 are open to participants now.

This study's planned enrollment of 60 is below the median of 163 across 210 interventional studies indexed under Death.

Browse Death studies →

Lead sponsor

Cukurova University is the lead sponsor of 259 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Be an actively enrolled second-year student in the Elderly Care Program. Be a volunteer. Maintain at least 80% attendance in the training sessions. Possess the ability to read, comprehend, and write in Turkish.

Exclusion criteria

Exclusion Criteria:

Having previously received training on death anxiety or spiritual care. Experiencing the loss of an immediate family member (parent, sibling, etc.) within the last 6 months.

Receiving medication or therapy for a psychiatric diagnosis. Submitting an incomplete or blank questionnaire. Failing to maintain at least 80% attendance in the training sessions.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Death and Spiritual Care Education

    Death and Spiritual Care in the Elderly group

    Behavioral: Death and Spiritual Care Education

  • Active comparator
    control group

    "Home Accidents and First Aid Among the Elderly" group

    Other: Control

Interventions

  • BehavioralDeath and Spiritual Care Education

    A 7-week curriculum on "Death and Spiritual Care in the Elderly" will be implemented.

  • OtherControl

    A 7-week curriculum on "Home Accidents Among the Elderly and First Aid" will be implemented.

06

What researchers measure

Primary outcomes

  1. Spirituality and Spiritual Care Rating Scale

    Developed by McSherry et al. (2002), this scale assesses individuals' perceptions of the concepts of spirituality and spiritual care. Its Turkish adaptation was conducted by Ergül and Temel Bayık (2007). The scale consists of 15 items in total, with the last four items being reverse-scored. It comprises three subdimensions and utilizes a five-point Likert-type format (1 = strongly agree → 5 = strongly disagree).

    Time frame: up to 12 months

  2. Attitude Scale Toward Death and the Terminally

    Developed by Kavas and Öztuna (2011), this scale consists of 23 items and uses a 4-point Likert-type format (1 = strongly agree → 4 = strongly disagree). Its subdimensions are: communication with terminally ill patients and their families, delegating care responsibilities, avoidance of death and terminally ill patients, and perceived self-efficacy. A higher score on the scale is interpreted as an increase in an "avoidant attitude" toward death and terminally ill patients.

    Time frame: up to 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07902531
Responsible party
Elif DAĞLI (Assoc. Prof., Cukurova University) — Principal investigator
First posted
Oct 29, 2026
Start date
Oct 22, 2026 (estimated)
Primary completion
May 28, 2027 (estimated)
Completion
Jun 28, 2027 (estimated)
Last update
Oct 29, 2026

Study contacts

Elif DAĞLI, Assoc. Prof.
Contact
elifarik90@gmail.com
+903223386560 ext. 146
Feyza AKTAŞ REYHAN, Assoc. Prof.
Contact
fyz.aktas@gmail.com
0090274260 00 43
Elif DAĞLI, Assoc. Prof.
principal investigator · Cukurova University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion